Definitive Healthcare (NASDAQ:DH) Announces Earnings Results, Beats Estimates By $0.02 EPS

Definitive Healthcare (NASDAQ:DH) issued its earnings results on Thursday. The company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02, FiscalAI reports. Definitive Healthcare had a negative net margin of 69.18% and a positive return on equity of 4.07%. The business had revenue of $54.65 million for the quarter, compared to analysts’ expectations of $54.58 million.

Definitive Healthcare Price Performance

NASDAQ DH traded up $0.02 on Friday, hitting $1.15. The stock had a trading volume of 324,402 shares, compared to its average volume of 394,086. Definitive Healthcare has a 52-week low of $0.61 and a 52-week high of $3.00. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.86 and a current ratio of 1.86. The company has a market capitalization of $122.76 million, a price-to-earnings ratio of 28.75, a price-to-earnings-growth ratio of 14.19 and a beta of 1.40. The firm has a 50-day moving average of $1.02 and a 200-day moving average of $1.06.

Wall Street Analysts Forecast Growth

DH has been the subject of a number of analyst reports. Morgan Stanley cut their price target on Definitive Healthcare from $2.50 to $1.50 and set an “equal weight” rating for the company in a report on Tuesday, August 11th. Wall Street Zen raised Definitive Healthcare from a “hold” rating to a “buy” rating in a report on Sunday, September 13th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $1.00 price objective on shares of Definitive Healthcare in a report on Wednesday, August 12th. Weiss Ratings upgraded Definitive Healthcare from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday. Finally, BTIG Research reaffirmed a “neutral” rating on shares of Definitive Healthcare in a report on Friday, September 4th. Six investment analysts have rated the stock with a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, Definitive Healthcare has an average rating of “Reduce” and a consensus price target of $1.47.

About Definitive Healthcare

Definitive Healthcare Corp. (NASDAQ: DH) provides data, analytics and commercial intelligence solutions for the healthcare industry. Its platform is designed to help organizations understand healthcare markets, identify business opportunities and make data-driven decisions.

The company serves pharmaceutical and biotechnology companies, medical device manufacturers, healthcare providers, hospitals and health systems, and other healthcare services organizations. Its offerings include information on healthcare providers and organizations, market intelligence, sales and marketing analytics, clinical trial insights, and tools that support commercial planning, market access and customer engagement.

Definitive Healthcare was founded in 2011 and became a publicly traded company in 2021.